(Total Views: 4807)
Posted On: 03/07/2017 11:21:29 AM
Post# of 171
ADXS-Advaxis Announces FDA Acceptance of IND for Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO
This is great news and will start triggering more milestone payments and with $4 per share in cash already ADXS is looking good.
This is great news and will start triggering more milestone payments and with $4 per share in cash already ADXS is looking good.
(0)
(0)Scroll down for more posts ▼
